10x Genomics Inc.

NASDAQ: TXG · Real-Time Price · USD
13.52
0.28 (2.11%)
At close: Aug 15, 2025, 12:41 PM

10x Genomics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
172.91M 154.88M 165.02M 151.65M 153.1M 141.01M 183.98M 153.64M 146.82M 134.28M 156.23M 131.07M 114.61M 114.5M 143.53M 125.3M 115.84M 105.82M
Cost of Revenue
47.82M 49.44M 54.07M 45.26M 46.21M 45.44M 77.91M 58.12M 47.21M 35.9M 36.83M 30.38M 27.7M 25.48M 27.6M 24.52M 4.92M 17.06M
Gross Profit
125.08M 105.44M 110.95M 106.39M 106.9M 95.57M 106.06M 95.53M 99.61M 98.39M 119.41M 100.69M 86.91M 89.02M 115.93M 100.78M 110.93M 88.76M
Operating Income
30.13M -39.33M -49.84M -41.48M -41.74M -59.4M -35.61M -94.8M -63.36M -51.99M -23.1M -40M -63.12M -41.73M -15.83M -15.88M -10.33M -10.22M
Interest Income
4.27M 3.69M 4.03M 4.97M 4.71M 4.74M 4.64M 4.3M 4.1M 3.87M 2.81M 2.02M 1.24M 569K 49K 49K 58K 50K
Pretax Income
37M -33.51M -48.38M -34.44M -37.08M -57.8M -46.6M -91.74M -60.77M -49.65M -16.41M -40.03M -63.83M -41.69M -15.99M -16.65M -9.96M -11.12M
Net Income
34.54M -34.36M -49.03M -35.75M -37.9M -59.95M -48.95M -92.99M -62.41M -50.75M -17.21M -41.91M -64.46M -42.41M -18.45M -17.17M -11.05M -11.55M
Selling & General & Admin
74.43M 89.73M 93.83M 81.7M 83.04M 84.67M 86.13M 82.42M 91.51M 83.28M 78.89M 73.4M 79.34M 66.67M 69.88M 62.08M 68.7M 56.9M
Research & Development
61.22M 64.25M 66.97M 66.17M 62.92M 68.64M 55.55M 107.91M 71.46M 67.1M 63.61M 67.29M 70.69M 64.08M 61.88M 54.58M 53.4M 41.88M
Other Expenses
n/a -9.2M n/a n/a n/a 1.66M n/a n/a -1.5M n/a n/a n/a n/a -400K 5K -599K 521K -729K
Operating Expenses
135.66M 144.77M 160.79M 147.88M 145.96M 154.97M 141.68M 190.32M 162.97M 150.38M 142.5M 140.69M 150.02M 130.75M 131.76M 116.66M 122.11M 98.79M
Interest Expense
3K n/a -8K 2K 1K 1K 8K 1K 5K 19K 125K 114K 109K 128K 217K 219K 209K 221K
Selling & Marketing Expenses
n/a n/a 3.9M n/a n/a n/a 3.3M n/a n/a n/a 3.7M n/a n/a n/a 4.7M n/a n/a n/a
Cost & Expenses
183.48M 194.21M 214.86M 193.14M 194.84M 200.4M 219.59M 248.44M 210.18M 186.27M 179.33M 171.07M 177.73M 156.23M 159.36M 141.18M 127.02M 115.85M
Income Tax Expense
2.46M 852K 648K 1.31M 818K 2.15M 2.35M 1.24M 1.65M 1.09M 804K 1.88M 627K 719K 2.46M 523K 1.09M 435K
Shares Outstanding (Basic)
123.76M 122.61M 121.6M 120.73M 120.07M 119.39M 118.57M 117.73M 116.71M 115.62M 114.76M 114.11M 113.57M 112.97M 111.9M 110.87M 109.87M 108.71M
Shares Outstanding (Diluted)
124.51M 122.61M 121.6M 120.73M 120.07M 119.39M 118.57M 117.73M 116.71M 115.62M 114.76M 114.11M 113.57M 112.97M 111.9M 110.87M 109.87M 108.71M
EPS (Basic)
0.28 -0.28 -0.4 -0.3 -0.32 -0.5 -0.41 -0.79 -0.53 -0.44 -0.15 -0.37 -0.57 -0.38 -0.16 -0.15 -0.1 -0.11
EPS (Diluted)
0.28 -0.28 -0.4 -0.3 -0.32 -0.5 -0.41 -0.79 -0.53 -0.44 -0.15 -0.37 -0.57 -0.38 -0.16 -0.15 -0.1 -0.11
EBITDA
46.65M -39.33M -37.82M -23.69M -26.18M -46.31M -34.88M -80.32M -48.88M -41.02M -7.81M -31.81M -55.28M -33.59M -8.45M -9.15M -2.56M -4.43M
EBIT
37M -33.51M -48.38M -34.44M -37.08M -57.8M -46.59M -91.74M -60.76M -49.63M -16.29M -39.92M -63.72M -41.57M -15.78M -16.43M -9.75M -10.89M
Depreciation & Amortization
9.65M 9.81M 10.56M 10.75M 10.9M 11.49M 11.71M 11.42M 11.88M 8.62M 8.47M 8.12M 8.44M 7.97M 7.32M 7.28M 7.19M 6.47M